Ostarine Magnus

Catalogue entry: Ostarine Magnus. Labelled content: 10 mg/tablet. Listed pack: 60 tablets. The amount identifies labelled product content, not an administration dose.

Identity and mechanism

Ostarine is commonly associated with enobosarm, also identified as GTx-024 or MK-2866. It is a nonsteroidal androgen-receptor modulator. The proposed distinction from conventional androgen therapy concerns relative tissue effects; selectivity does not mean that other hormone-sensitive tissues are unaffected.

What the research measured

Dalton and colleagues reported a phase II trial in older men and postmenopausal women in the Journal of Cachexia, Sarcopenia and Muscle in 2011. The study assessed lean mass and physical-function measures. Its population and endpoints should remain visible when discussing results: a clinical function test is not evidence of general performance enhancement in trained athletes.

Sporting claims and limitations

Comparisons with Ligandrol are common in physique discussions, but there is no simple equivalence between the compounds or their trial findings. Changes in liver enzymes, lipids and hormonal markers are relevant to benefit-risk interpretation. Broader SARM warnings include liver injury and cardiovascular concerns. A short study cannot establish the safety of repeated use or combinations.

Product identity and documentation

Check the labelled amount against the selected product photograph and source record. In this catalogue, source discrepancies are retained for review rather than corrected by altering an image. A batch-specific identity result, method and lot reference are more informative than an attractive label or an isolated purity percentage. Clinical enobosarm research does not certify an unrelated retail vial or bottle.